US 2016/0108096 A1 · FUSION PROTEINS, RECOMBINANT BACTERIA, AND METHODS FOR USING RECOMBINANT BACTERIA

Abstract

Fusion proteins containing a targeting sequence, an exosporium protein, or an exosporium protein fragment that targets the fusion protein to the exosporium of a Bacillus cereus family member are provided. Recombinant Bacillus cereus family members expressing such fusion proteins are also provided. Genetically inactivated Bacillus cereus family members and recombinant Bacillus cereus family members that overexpress exosporium proteins are also provided. Seeds coated with the recombinant Bacillus cereus family members and methods for using the recombinant Bacillus cereus family members (e.g., for stimulating plant growth) are also provided. Various modifications of the recombinant Bacillus cereus family members that express the fusion proteins are further provided. Fusion proteins comprising a spore coat protein and a protein or peptide of interest, recombinant bacteria that express such fusion proteins, seeds coated with such recombinant bacteria, and methods for using such recombinant bacteria (e.g., for stimulating plant growth) are also provided.

A fusion protein comprising at least one protein or peptide of interest and:

(1) a targeting sequence comprising amino acids 1-30 of SEQ ID NO:
59;
(2) a targeting sequence comprising SEQ ID NO:
59;
(3) an exosporium protein comprising an amino acid sequence having at least 85% identity with SEQ ID NO:
60;
(4) a targeting sequence comprising amino acids 2-30 of SEQ ID NO:
59;
(5) a targeting sequence comprising amino acids 4-30 of SEQ ID NO:
59;
(6) a targeting sequence comprising amino acids 6-30 of SEQ ID NO:
59;
(7) a targeting sequence comprising amino acids 1-33 of SEQ ID NO:
61;
(8) a targeting sequence comprising amino acids 18-33 of SEQ ID NO:
61;
(9) a targeting sequence comprising SEQ ID NO:
61;
(10) an exosporium protein comprising an amino acid sequence having at least 85% sequence identity with SEQ ID NO:
62;
(11) a targeting sequence comprising amino acids 2-33 of SEQ ID NO:
61;
(12) a targeting sequence comprising amino acids 5-33 of SEQ ID NO:
61;
(13) a targeting sequence comprising amino acids 10-33 of SEQ ID NO:
61;
(14) a targeting sequence comprising amino acids 15-33 of SEQ ID NO:
61;
(15) a targeting sequence comprising amino acids 1-35 of SEQ ID NO:
63;
(16) a targeting sequence comprising SEQ ID NO:
63;
(17) an exosporium protein comprising an amino acid sequence having at least 85% identity with SEQ ID NO:
64;
(18) a targeting sequence comprising amino acids 2-35 of SEQ ID NO:
63;
(19) a targeting sequence comprising amino acids 5-35 of SEQ ID NO:
63;
(20) a targeting sequence comprising amino acids 8-35 of SEQ ID NO:
63;
(21) a targeting sequence comprising amino acids 10-35 of SEQ ID NO:
63;
(22) a targeting sequence comprising amino acids 15-35 of SEQ ID NO:
63;
(23) a targeting sequence comprising amino acids 1-24 of SEQ ID NO:
65;
(24) a targeting sequence comprising amino acids 9-24 of SEQ ID NO:
65;
(25) a targeting sequence comprising SEQ ID NO:
65;
(26) an exosporium protein comprising an amino acid sequence having at least 85% identity with SEQ ID NO:
66;
(27) a targeting sequence comprising SEQ ID NO:
107;
(28) a targeting sequence comprising amino acids 2-24 of SEQ ID NO:
65;
(29) a targeting sequence comprising amino acids 5-24 of SEQ ID NO:
65;
(30) a targeting sequence comprising amino acids 1-27 of SEQ ID NO:
67;
(31) a targeting sequence comprising amino acids 12-27 of SEQ ID NO:
67;
(32) a targeting sequence comprising SEQ ID NO:
67;
(33) an exosporium protein comprising an amino acid sequence having at least 85% identity with SEQ ID NO:
68;
(34) an targeting sequence comprising amino acids 2-27 of SEQ ID NO:
67;
(35) a targeting sequence comprising amino acids 5-27 of SEQ ID NO:
67;
(36) a targeting sequence comprising amino acids 10-27 of SEQ ID NO:
67;
(37) a targeting sequence comprising amino acids 1-38 of SEQ ID NO:
69;
(38) a targeting sequence comprising amino acids 23-38 of SEQ ID NO:
69;
(39) a targeting sequence comprising SEQ ID NO:
69;
(40) an exosporium protein comprising an amino acid sequence having at least 85% identity with SEQ ID NO:
70;
(41) a targeting sequence comprising amino acids 2-38 of SEQ ID NO:
69;
(42) a targeting sequence comprising amino acids 5-38 of SEQ ID NO:
69;
(43) a targeting sequence comprising amino acids 10-38 of SEQ ID NO:
69;
(44) a targeting sequence comprising amino acids 15-38 of SEQ ID NO:
69;
(45) an exosporium protein comprising SEQ ID NO:
72;
(46) a targeting sequence comprising SEQ ID NO:
73;
(47) an exosporium protein comprising an amino acid sequence having at least 95% identity with SEQ ID NO:
74;
(48) a targeting sequence comprising amino acids 1-42 of SEQ ID NO:
75;
(49) a targeting sequence comprising amino acids 27-42 of SEQ ID NO:
75;
(50) a targeting sequence comprising SEQ ID NO:
75;
(51) an exosporium protein comprising an amino acid sequence having at least 85% identity with SEQ ID NO:
76;
(52) a targeting sequence comprising amino acids 2-42 of SEQ ID NO:
75;
(53) a targeting sequence comprising amino acids 5-42 of SEQ ID NO:
75;
(54) a targeting sequence comprising amino acids 10-42 of SEQ ID NO:
75;
(55) a targeting sequence comprising amino acids 15-42 of SEQ ID NO:
75;
(56) a targeting sequence comprising amino acids 20-42 of SEQ ID NO:
75;
(57) a targeting sequence comprising amino acids 25-42 of SEQ ID NO:
75;
(58) a targeting sequence comprising amino acids 1-24 of SEQ ID NO:
77;
(59) a targeting sequence comprising amino acids 9-24 of SEQ ID NO:
77;
(60) a targeting sequence comprising SEQ ID NO:
77;
(61) an exosporium protein comprising an amino acid sequence having at least 85% identity with SEQ ID NO:
78;
(62) a targeting sequence comprising amino acids 2-24 of SEQ ID NO:
77;
(63) a targeting sequence comprising amino acids 5-24 of SEQ ID NO:
77;
(64) an exosporium protein comprising an amino acid sequence having at least 85% identity with SEQ ID NO:
80;
(65) a targeting sequence comprising amino acids 1-38 of SEQ ID NO:
81;
(66) a targeting sequence comprising amino acids 23-38 of SEQ ID NO:
81;
(67) a targeting sequence comprising SEQ ID NO:
81;
(68) an exosporium protein comprising an amino acid sequence having at least 85% identity with SEQ ID NO:
82;
(69) a targeting sequence comprising amino acids 2-38 of SEQ ID NO:
81;
(70) a targeting sequence comprising amino acids 5-38 of SEQ ID NO:
81;
(71) a targeting sequence comprising amino acids 10-38 of SEQ ID NO:
81;
(72) a targeting sequence comprising amino acids 15-38 of SEQ ID NO:
81;
(73) a targeting sequence comprising amino acids 20-38 of SEQ ID NO:
81;
(74) a targeting sequence comprising amino acids 1-34 of SEQ ID NO:
83;
(75) a targeting sequence comprising SEQ ID NO:
83;
(76) an exosporium protein comprising an amino acid sequence having at least 85% identity with SEQ ID NO:
84;
(77) an exosporium protein comprising an amino acid sequence having at least 85% identity with SEQ ID NO:
86;
(78) a targeting sequence comprising amino acids 1-28 of SEQ ID NO:
87;
(79) a targeting sequence comprising amino acids 13-28 of SEQ ID NO:
87;
(80) a targeting sequence comprising SEQ ID NO:
87;
(81) an exosporium protein comprising an amino acid sequence having at least 85% identity with SEQ ID NO:
88;
(82) a targeting sequence comprising amino acids 2-28 of SEQ ID NO:
87;
(83) a targeting sequence comprising amino acids 5-28 of SEQ ID NO:
87;
(84) a targeting sequence comprising amino acids 10-28 of SEQ ID NO:
87;
(85) a targeting sequence comprising amino acids 1-28 of SEQ ID NO:
89;
(86) a targeting sequence comprising SEQ ID NO:
89;
(87) an exosporium protein comprising an amino acid sequence having at least 85% identity with SEQ ID NO:
90;
(88) a targeting sequence comprising amino acids 2-28 of SEQ ID NO:
89;
(89) a targeting sequence comprising amino acids 5-28 of SEQ ID NO:
89;
(90) a targeting sequence comprising amino acids 10-28 of SEQ ID NO:
89;
(91) a targeting sequence comprising amino acids 1-93 of SEQ ID NO:
91;
(92) a targeting sequence comprising SEQ ID NO:
91;
(93) an exosporium protein comprising an amino acid sequence having at least 85% identity with SEQ ID NO:
92;
(94) a targeting sequence comprising amino acids 2-93 of SEQ ID NO:
91;
(95) a targeting sequence comprising amino acids 10-93 of SEQ ID NO:
91;
(96) a targeting sequence comprising amino acids 20-93 of SEQ ID NO:
91;
(97) a targeting sequence comprising amino acids 30-93 of SEQ ID NO:
91;
(98) a targeting sequence comprising amino acids 40-93 of SEQ ID NO:
91;
(99) a targeting sequence comprising amino acids 50-93 of SEQ ID NO:
91;
(100) a targeting sequence comprising amino acids 60-93 of SEQ ID NO:
91;
(101) a targeting sequence comprising amino acids 1-130 of SEQ ID NO:
93;
(102) a targeting sequence comprising SEQ ID NO:
93;
(103) an exosporium protein comprising an amino acid sequence having at least 85% identity with SEQ ID NO:
94;
(104) a targeting sequence comprising amino acids 2-130 of SEQ ID NO:
93;
(105) a targeting sequence comprising amino acids 10-130 of SEQ ID NO:
93;
(106) a targeting sequence comprising amino acids 20-130 of SEQ ID NO:
93;
(107) a targeting sequence comprising amino acids 30-130 of SEQ ID NO:
93;
or
(108) an exosporium protein comprising an amino acid sequence having at least 85% sequence identity with SEQ ID NO:
122.

214 more elements

Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria

Life of this patent

Fusion proteins, recombinant bacteria, and methods for using recombinant bacteria

Life of this patent

Abstract

Claims33